MedQuist Holdings Adds Two Independent Directors
19 Octubre 2011 - 7:55PM
MedQuist Holdings Inc. (Nasdaq:MEDH), ("the Company") a leading
provider of integrated clinical documentation solutions for the
U.S. healthcare industry, today announced that its board of
directors elected Robert J. Greczyn, Jr. and Andrew E. Vogel to the
board, expanding the size of the board to eleven members and
increasing the number of independent directors to four.
"Our top corporate governance objective is to have a majority
independent board by early February 2012," noted Vern Davenport,
Chairman and Chief Executive Officer of MedQuist Holdings. "Today's
announcement puts us well on the way to meeting that objective. Bob
and Andrew's wealth of healthcare and financial expertise should
provide valuable input and direction as we execute our growth
strategy. We look forward to their contributions to our continued
growth."
Mr. Greczyn was with Blue Cross and Blue Shield of North
Carolina ("BCBSNC") from 1998 until his retirement in February
2010, where he served as the President and Chief Executive Officer
since April 2000, the President and Chief Operating Officer from
September 1999 to April 2000, and the Executive Vice President and
Chief Operating Officer from August 1998 to September 1999.
Prior to joining BCBSNC, Mr. Greczyn was the President and Chief
Executive Officer of Healthsource North Carolina, Inc. from April
1990 until June 1997. From June 1997 to January 1998, he was
appointed to serve as the President and Chief Executive Officer of
Healthsource North Carolina and Healthsource North Carolina
Administrators while the companies were integrated into CIGNA
Healthcare Inc. Since retiring in February 2010, Mr. Greczyn
has served on the boards of private companies and invested in early
stage start-up companies. Mr. Greczyn has a B.A. from East
Carolina University and an M.P.H. from the University of North
Carolina - Chapel Hill.
Mr. Vogel is a Managing Member of ZM Capital, a media and
communications focused private equity firm, and has been working at
ZelnickMedia Corp. since November 2003. Prior to joining
ZelnickMedia, Mr. Vogel was an investment professional at
Ripplewood Holdings. Previously, Mr. Vogel was an investment
professional at McCown De Leeuw & Co. and an investment banker
in Lehman Brothers' Mergers and Acquisitions group. Mr. Vogel
served as a member of the MedQuist Inc. board of directors from
September 2008 to March 2011 and served as a member of the MedQuist
Inc. Audit Committee. Mr. Vogel is also a director of several
privately held companies, including CRT Holdings, LLC, Airvana
Network Solutions, Inc. and Alloy Media Investments, L.L.C. Mr.
Vogel has a B.A. from Wesleyan University and an M.B.A. from
Harvard Business School.
About MedQuist Holdings
MedQuist is a leading provider of clinical narrative capture
services, Speech Understanding technology from M*Modal and clinical
documentation workflow. MedQuist's enterprise solutions – including
mobile voice capture devices, speech recognition, Web-based
workflow platforms and global network of medical editors – help
healthcare facilities facilitate adoption of electronic health
records (EHR), improve patient care, increase physician
satisfaction and lower operational costs. For more information,
please visit www.medquist.com.
Forward-Looking Statements
Information provided and statements contained in this press
release that are not purely historical, such as
statements regarding the timing of the majority independence of the
board of directors, are forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, Section 21E
of the Securities Exchange Act of 1934 and the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements only
speak as of the date of this press release and the Company assumes
no obligation to update the information included in this press
release. Statements made in this press release that are
forward-looking in nature may involve risks and uncertainties.
Accordingly, readers are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject
to certain risks, uncertainties and assumptions that are difficult
to predict, including, without limitation, specific factors
discussed herein and in other releases and public filings made by
the Company (including filings by the Company with the SEC).
Although the Company believes that the expectations reflected in
such forward-looking statements are reasonable as of the date made,
expectations may prove to have been materially different from the
results expressed or implied by such forward-looking statements.
Unless otherwise required by law, the Company also disclaims any
obligation to update its view of any such risks or uncertainties or
to announce publicly the result of any revisions to the
forward-looking statements made in this press release.
CONTACT: Investor Contacts:
Ron Scarboro
Chief Financial Officer
ronald.scarboro@medquist.com
(615) 798-4350
Tripp Sullivan
Corporate Communications, Inc.
tripp.sullivan@cci-ir.com
(615) 324-7335
Media Contact:
Thomas Mitchell
Director of Marketing
tmitchell@medquist.com
(615) 798-6630
Medx (CE) (USOTC:MEDH)
Gráfica de Acción Histórica
De May 2024 a May 2024
Medx (CE) (USOTC:MEDH)
Gráfica de Acción Histórica
De May 2023 a May 2024